301.000
+4,33%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -14.8% | -9.7% | 0 / 3 | -3.6% | -0.19 pp | -2.22 pp | +32.3% | 0.10 | 16.53 | 613 | −3,6% | 103 | −14,8% | 16.53 | 15.33 | +7,8% |
| Pts | 0 | 0 | 0 | 0 | 4 | 0 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 301.000 (close price on 2026-10-19)EPS (TTM): 18.211
Financial charts
1.Revenue & growth
VND bn613Q2/26
1.Revenue & growth
VND bn613Q2/26
2.Profit & growth
VND bn103Q2/26
3.Profit mix (Penman)
VND bn605Q2/26
4.Margins & cost structure
%21.3%Q2/26
5.Returns & cash cycle
% · days35.0%Q2/26
6.Earnings quality & cash
VND bn594Q2/26
7.Asset structure
VND bn1.793Q2/26
8.Funding & debt health
VND bn · times1.793Q2/26
9.Revenue backlog
VND bn0,95Q2/26
10.Valuation
times · %16,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.881Q2/26
Adjusted EPS growth, latest quarter
-14.8%
Average adjusted EPS growth, 3 quarters
-9.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26